Troutman Pepper Locke LLP is active in complex pharmaceutical and medical device litigation spanning MDLs, coordinated proceedings, and individual high-exposure claims. Ronni Fuchs, in Princeton, leads defense efforts in litigation alleging contamination of generic metformin. Sean Fahey, based in Philadelphia, serves as lead and liaison counsel for brand manufacturers in federal MDLs, including cases involving heater-cooler systems used in open-heart surgery that are alleged to have caused non-tuberculous mycobacterial infections. Fuchs and Fahey also act as coordinating counsel in personal injury matters alleging that specialized infant formula caused serious gastrointestinal disease and that ethylene oxide used to sterilize medical devices resulted in cancer. Both individuals lead the team. In Philadelphia, Hyung Steele handles opioid MDL personal injury actions involving allegations of developmental disabilities in children, while Barry Boise, also in Philadelphia, represents clients in litigation arising from clinical trials allegedly causing significant injuries.
Legal 500 Editorial commentary
Key clients
- Abbott Laboratories
- Boehringer Ingelheim
- Amneal Pharmaceuticals
- Becton Dickinson
- LivaNova USA
- B. Braun Medical
- Eco-Energy
- Sun Pharmaceuticals
Practice head
Ronni Fuchs; Sean Fahey
Other key lawyers
Barry Boise; Hyung Steele
